Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

Th17 tissue metab

Financiado

Metabolic imprinting of Th17 cells in disease pathogenesis

Autoimmune diseases affect an estimated 3-9% of the population and cause major personal and socio-economic consequences. IL-17-producing CD4+ T cells (Th17) are recruited to inflamed tissues and involved in autoimmune pathogenesis... ver más

31/08/2025

UNI WUERZBURG

266K€

Presupuesto del proyecto: 266K€

Líder del proyecto

JULIUSMAXIMILIANSUNIVERSITAT WURZBURG No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 3 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-06-26

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

HORIZON-MSCA-2021-PF-01-01: MSCA Postdoctoral Fellowships 2021

I+D

Cerrada hace 3 años

0% 100%

3 Participantes

UNI WUERZBURG

265.65K€ | Lider

BRIGHAM INC

N.D. | Participante

Proyectos interesantes

Remin-T Dissecting the molecular basis of immunological memory in hu... 188K€ Cerrado

SAF2017-88086-R CELULAS MIELOIDES Y PLASTICIDAD EPIGENETICA: MECANISMOS E IM... 290K€ Cerrado

CNS2023-143622 Inmunidad, infección e inmunoterapia 168K€ Cerrado

PID2020-117212RB-I00 ENTENDIENDO EL PAPEL DE LA COMUNICACION CELULAR EN EL SISTEM... 339K€ Cerrado

SAF2014-55942-R MECANISMOS DE REGULACION EPIGENETICA EN PROCESOS DE DIFERENC... 278K€ Cerrado

MAIT-TraDe Development and trafficking of type 1 and type 17 mucosal-as... 196K€ Cerrado

Últimas noticias

29-11-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

29-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 2 concesiones

29-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 37 concesiones

Duración del proyecto: 38 meses Fecha Inicio: 2022-06-26
Fecha Fin: 2025-08-31

Líder del proyecto

JULIUSMAXIMILIANSUNIVERSITAT WURZBURG

TRL 4-5

Presupuesto del proyecto 266K€

Descripción del proyecto Autoimmune diseases affect an estimated 3-9% of the population and cause major personal and socio-economic consequences. IL-17-producing CD4+ T cells (Th17) are recruited to inflamed tissues and involved in autoimmune pathogenesis but were recently also shown to have homeostatic function in tissues. Preliminary data from the outgoing host indicate that Th17 cells are transcriptionally distinct in different tissues. How tissue Th17 cells acquire such specialized characteristics remains elusive. Based on recent findings from the lab that a metabolic manipulation affects Th17 cells, we hypothesize that metabolic cues from the target tissue dictate Th17 phenotypes. To address this, we will apply scRNAseq and the host lab developed Compass metabolic flux tool in 9 tissues. Hits from this analysis will undergo a novel screening approach, CHIME, to reveal effects on Th17 function. In autoimmunity, Th17 cells reside within different tissues before migrating to the inflamed tissue. Identifying a tissue metabolic switch for Th17 cell pathogenicity might thus pave the way for novel treatments. To study this, I will use a mouse model for the autoimmune disease multiple sclerosis (MS) for target validation. During the return phase, the findings will be set into context of tissue niche immunology and human biology. In healthy versus inflamed human tissue, spatial RNAseq will directly reveal metabolism related differences in a natural tissue niche context. The project will be performed in a world-renowned Th17 lab. The fellow brings extensive experience with tissue immune cell extractions and MS mouse models, enabling immediate project progression. The fellow will then bring back novel techniques and experience (scRNAseq, CHIME) to the return host, where she will acquire skills in human tissue niche immunology and spatial RNAseq. This project will enhance her expertise, research and transferable skills and allow to build a network to follow her goal of becoming an independent PI.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores